Literature DB >> 14871457

Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function.

S Müller1, L Ronfani, M E Bianchi.   

Abstract

High mobility group box protein 1 (HMGB1) has been considered as a ubiquitous nuclear protein with an architectural function, but even early reports have described its presence outside of the nucleus. Today, we have only started to understand the extranuclear and extracellular functions of HMGB1: we know that it participates in developmental and differentiation processes, triggers and modulates many of the inflammatory cascades in the body, and may even be involved in the metastatic invasion programme of cancer cells. Given such diverse roles, it is important to know which cells express HMGB1, where, and how much. The present review deals with the expression pattern of HMGB1 and provides evidence that, far from being housekeeping, the HMGB1 gene is tightly regulated. This can have implications for therapeutic intervention on inflammatory diseases as well as cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871457     DOI: 10.1111/j.1365-2796.2003.01296.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  130 in total

1.  High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

Authors:  Yoko Oyama; Teruto Hashiguchi; Noboru Taniguchi; Salunya Tancharoen; Tomonori Uchimura; Kamal K Biswas; Ko-Ichi Kawahara; Takao Nitanda; Yoshihisa Umekita; Martin Lotz; Ikuro Maruyama
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

2.  Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.

Authors:  Hiromasa Takaishi; Takanori Kanai; Atsushi Nakazawa; Fumihiko Sugata; Akira Nikai; Shigeo Yoshizawa; Yasuo Hamamoto; Shinsuke Funakoshi; Tomoharu Yajima; Yasushi Iwao; Masao Takemura; Shoichi Ozaki; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-05-30       Impact factor: 7.527

3.  Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.

Authors:  K Völp; M-L Brezniceanu; S Bösser; T Brabletz; T Kirchner; D Göttel; S Joos; M Zörnig
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

4.  Arabidopsis chromatin-associated HMGA and HMGB use different nuclear targeting signals and display highly dynamic localization within the nucleus.

Authors:  Dorte Launholt; Thomas Merkle; Andreas Houben; Alexander Schulz; Klaus D Grasser
Journal:  Plant Cell       Date:  2006-11-17       Impact factor: 11.277

Review 5.  HMG chromosomal proteins in development and disease.

Authors:  Robert Hock; Takashi Furusawa; Tetsuya Ueda; Michael Bustin
Journal:  Trends Cell Biol       Date:  2006-12-13       Impact factor: 20.808

Review 6.  Determinants of histone H1 mobility and chromatin binding in living cells.

Authors:  Frédéric Catez; Tetsuya Ueda; Michael Bustin
Journal:  Nat Struct Mol Biol       Date:  2006-04       Impact factor: 15.369

Review 7.  Plant proteins containing high mobility group box DNA-binding domains modulate different nuclear processes.

Authors:  Martin Antosch; Simon A Mortensen; Klaus D Grasser
Journal:  Plant Physiol       Date:  2012-05-14       Impact factor: 8.340

8.  Association Between HMGB1 and Thrombogenesis in a Hyperlipaemia-induced Microminipig Model of Atherosclerosis.

Authors:  Satoru Kake; Hiroaki Kawaguchi; Tomoka Nagasato; Tomonobu Yamada; Takashi Ito; Ikuro Maruyama; Naoki Miura; Akihide Tanimoto
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 9.  The role of neuroimmune signaling in alcoholism.

Authors:  Fulton T Crews; Colleen J Lawrimore; T Jordan Walter; Leon G Coleman
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

10.  The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.

Authors:  Toru Takeda; Hiroto Izumi; Shohei Kitada; Hidetaka Uramoto; Takashi Tasaki; Li Zhi; Xin Guo; Yuichiro Kawatsu; Tomoko Kimura; Seichi Horie; Atsunori Nabeshima; Hirotsugu Noguchi; Ke-Yong Wang; Yasuyuki Sasaguri; Kimitoshi Kohno; Sohsuke Yamada
Journal:  Tumour Biol       Date:  2014-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.